|
2025
|
P/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
P/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
P/S
|
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatm... |
|
|
P/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
Invention
|
Cblb endonuclease variants, compositions, and methods of use.
The present disclosure provides im... |
|
|
Invention
|
N-terminal scfv multispecific binding molecules.
Multispecific binding molecules (MBMs) comprisi... |
|
|
Invention
|
Systems and methods for producing a mixer.
Systems and method for producing a small-scale mixer ... |
|
|
Invention
|
Protein a chromatography - electrospray ionization mass spectrometer.
Methods and system for cha... |
|
|
Invention
|
Hydrophobic interaction chromatography for viral clearance.
The present application provides a m... |
|
|
Invention
|
Process for reducing subvisible particles in a pharmaceutical formulation.
The present disclosur... |
|
|
Invention
|
Use of a vegf antagonist to treat angiogenic eye disorders.
The present invention provides metho... |
|
|
Invention
|
Antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof.
Described herein are ... |
|
|
Invention
|
Devices and methods for precision dose delivery.
Disclosed herein are devices and methods for de... |
|
|
Invention
|
Anti-pcsk9 antibodies.
An human antibody or antigen-binding fragment of a human antibody that sp... |
|
|
Invention
|
Eukaryotic cells comprising adenovirus-associated virus polynucleotides.
The present inventions ... |
|
|
Invention
|
Auto-injector and related methods of use.
An injection device includes a carrier, a needle, a dr... |
|
2024
|
Invention
|
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr a... |
|
|
Invention
|
Compositions and methods for internalizing enzymes.
Compositions and methods for treating enzyme... |
|
|
Invention
|
Il18 receptor agonists and methods of use thereof.
The present disclosure relates to IL18 recept... |
|
|
Invention
|
Methods of treating cancer by administering a combination therapy including a neoadjuvant pd-1 in... |
|
|
Invention
|
Methods of treating recurrent ovarian cancer and endometrial cancer with bispecific anti-muc16 x ... |
|
|
Invention
|
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses ... |
|
|
Invention
|
Methods of treating skin cancer with histidine ammonia-lyase (hal) agonists.
The present disclos... |
|
|
Invention
|
Covalently surface modified adeno-associated virus production by in vitro conjugation, and purifi... |
|
|
Invention
|
Capacitance probe and cell culture failure modes.
The present invention generally pertains to me... |
|
|
Invention
|
Structure and function characterization of adeno-associated virus (aav) by hdx-ms.
The present d... |
|
|
Invention
|
Structure and function characterization of adeno-associated virus (aav) by hdx-ms. The present di... |
|
|
Invention
|
Combination of pd-1 inhibitors and lag-3 inhibitors for enhanced efficacy in treating lung cancer... |
|
|
Invention
|
Systems and methods for producing small-scale mixers for drug manufacturing. Disclosed herein are... |
|
|
Invention
|
Engineered heavy chain variable domains and uses thereof. The present disclosure relates to engin... |
|
|
Invention
|
Systems and methods for producing small-scale mixers for drug manufacturing.
Disclosed herein ar... |
|
|
Invention
|
Systems and methods for drug delivery to ocular tissue. Disclosed are devices and methods for fac... |
|
|
Invention
|
Engineered alpha klotho polypeptides and uses thereof.
The present disclosure provides engineere... |
|
|
Invention
|
Engineered alpha klotho polypeptides and uses thereof. The present disclosure provides engineered... |
|
|
Invention
|
Systems and methods for drug delivery to ocular tissue.
Disclosed are devices and methods for fa... |
|
|
Invention
|
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof.
Described herein are prot... |
|
|
Invention
|
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof. Described herein are prote... |
|
|
Invention
|
Methods for reducing lipase activity using stress.
Pharmaceutical formulations comprising an ant... |
|
|
Invention
|
Methods for reducing lipase activity using stress. Pharmaceutical formulations comprising an anti... |
|
|
Invention
|
Predictive biomarkers in patients with follicular lymphoma and diffuse large b-cell lymphoma. The... |
|
|
Invention
|
Stable antibody formulation.
The present invention provides stable pharmaceutical formulations c... |
|
|
Invention
|
Stable antibody formulation comprising fianlimab. The present invention provides stable pharmaceu... |
|
|
Invention
|
Treatment of osteoarthritis with procollagen galactosyl transferase 2 (colgalt2) inhibitors. The ... |
|
|
Invention
|
Treatment of non-small cell lung cancer with 6-thio-dg and cemiplimab. Disclosed herein are metho... |
|
|
Invention
|
Treatment of myeloid cell dysfunction with membrane spanning 4-domains a6a (ms4a6a) inhibitors. T... |
|
|
Invention
|
Treatment of myeloid cell dysfunction with membrane spanning 4-domains a6a (ms4a6a) inhibitors.
... |
|
|
Invention
|
Treatment of smoking with cholinergic receptor nicotinic beta 3 subunit (chrnb3) inhibitors.
The... |
|
|
Invention
|
Compositions and methods comprising engineered short nuclear rna (snrna).
SnRNA systems comprisi... |
|
2023
|
Invention
|
Combinations of checkpoint inhibitors and oncolytic virus for treating cancer.
The present discl... |
|
|
Invention
|
Microtubule associated protein tau (mapt) irna agent compositions and methods of use thereof.
Th... |
|
2022
|
Invention
|
Biochemical assays for therapeutic proteins.
The present invention generally pertains to methods... |
|
2021
|
Invention
|
Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor.
The present d... |
|
2020
|
Invention
|
Cell culture medium. The present disclosure provides improved cell culture media for maintaining ... |
